Chain for claim_ce09fa4594a94210
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_ce09fa4594a94210
# Source literature boundary memo ## Research question Across retrieved source-level receipts for empagliflozin, which endpoints show directionally favorable versus null/non-convergent signals, and what matched PICO remains untested? ## Selection criteria The source-literature selector kept empagliflozin because the candidate bundle met the public source rule: 5 citable papers, 5 distinct fact…
sha256 c655740df4fc9c42…
depth 1 · source
source_33f4d7ab1ca94d54
# Source literature boundary memo ## Research question Across retrieved source-level receipts for empagliflozin, which endpoints show directionally favorable versus null/non-convergent signals, and what matched PICO remains untested? ## Selection criteria The source-literature selector kept empagliflozin because the candidate bundle met the public source rule: 5 citable papers, 5 distinct fact…
sha256 4093ed604633c685…
depth 1 · source
source_fb63a37ad1064e06
{"publication_id": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "traces": [{"candidate_sources": [{"directness": "review-level", "doi": "10.1093/eurjpc/zwab173", "effect": "not extracted", "endpoint": "not extracted", "population": "patients with T2DM and/or HF", "source_id": "source_1", "study": "Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-a…
sha256 bf155e826fdcb2ee…
depth 1 · source
source_44211ecea3de422d
{"content_hash": null, "edges": [{"from": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "to": "claim_1", "type": "contains_claim"}, {"from": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "to": "claim_2", "type": "contains_claim"}, {"from": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "to": "claim_3", "type": "contains_claim"}, {"from": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "to": "claim_4", "type": "contains_clai…
sha256 ac34db711aa987e4…
depth 1 · source
source_a8225976d08d4209
{"contradictions": ["This receipt-backed scoping note has one bounded signal: empagliflozin shows directionally consistent signals across heterogeneous contexts across this 5-source primary/review bundle (2016-2023). Evidence role grouping: direction-bearing receipts: 5; null/mixed metric-scope caveat receipts: 0. The source facts cover 5 population/setting context(s) and 2 intervention/exposure c…
sha256 e65fd0c59b05c5b8…
depth 1 · source
source_e65a5d28f8d3493d
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis,patients with T2DM and/or HF,empagliflozin,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium…
sha256 f0b67fb43c414bd6…
depth 1 · source
source_c0c53b9322e3421d
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "ba51abd9-ce97-48b3-b9e2-eb5a53bbd780", "sources": [{"directness": "review-level", "doi": "10.1093/eurjpc/zwab173", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of sodium-glucose cotransporter-2 inhibitors on cardia…
sha256 775ac90c74cf29ea…
depth 1 · source
source_f6f3692a44754ed6
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 9efcb2f28256fbbd…